• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 1012015-120
Device Problems Stretched (1601); Difficult or Delayed Activation (2577); Noise, Audible (3273); Physical Resistance/Sticking (4012)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/13/2024
Event Type  malfunction  
Event Description
It was reported the procedure was to treat a partly subintimal chronic total occlusion in the mid superficial femoral artery (sfa).The 6.0x120mm absolute pro ll self expanding stent system (ses) was placed in the target lesion however the thumbwheel stopped turning after a few rotations and a crack was heard, the stent only deployed 5mm.The delivery system was retracted and the stent was deployed however it elongated and was partially deployed in healthy tissue.A supera stent was deployed in the target lesion inside the absolute pro stent to complete the procedure.There was no clinically significant delay in the procedure and no adverse patient effects.No additional information was provided.
 
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Manufacturer Narrative
Corrections: b1 - adverse event/product problem added adverse event.B2 - outcomes attributed to ae updated from "na" to "required intervention".H6- health effect - impact code 2199 was removed and replaced with code 4641.H6- medical device problem code 2017 clarifier: failure to follow steps/instructions.The device was returned for analysis.The reported physical resistance, difficult/delayed activation, noise, and stretched were unable to be replicated in a testing environment due to the condition of the returned device.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.Reportedly, an.018 guide wire was used.Use of an undersized guide wire, with insufficient support, may cause kinking in the stent delivery system.It should be noted the absolute pro ll peripheral self-expanding stent system instructions for use (ifu) states: one 0.035" (0.89 mm) diameter guide wire.As the deviation of the ifu appears to have contributed to the reported difficulties the deviation of the ifu will be addressed in the account requested letter.As there was no damage noted to the device during the inspection prior to use, the investigation determined the reported difficulties appear to be related to deviation of the instructions for use and subsequent circumstances of the procedure as it is likely that during advancement use of the undersized.018¿ guide wire in conjunction with interaction with the anatomy resulted in bending the device such that it prevented the shaft lumens from moving freely causing resistance; thus during stent deployment resulted in the reported thumbwheel ¿crack sound¿, the reported thumbwheel physical resistance and ultimately resulted in the reported stent deployment difficulties.Manipulation of the compromised device resulted in the noted wrinkled sheath likely contributing to the reported deployment difficulties.Interaction with the anatomy and/or other devices during retraction of the compromised device resulted in the reported stretched stent as it was inadvertently partially deployed in healthy tissue.As reported, a supera stent was deployed in the target lesion inside the absolute pro stent to complete the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported the procedure was to treat a partly subintimal chronic total occlusion in the mid superficial femoral artery (sfa).The 6.0x120mm absolute pro ll self expanding stent system (ses) was placed in the target lesion however the thumbwheel stopped turning after a few rotations and a crack was heard, the stent only deployed 5mm.The delivery system was retracted and the stent was deployed however it elongated and was partially deployed in healthy tissue.A supera stent was deployed in the target lesion inside the absolute pro stent to complete the procedure.There was no clinically significant delay in the procedure and no adverse patient effects.No additional information was provided.Subsequent to the previously filed report, additional information was received that the wrong size guidewire was used with the absolute pro ll.A duplicate event for this device was filed under mdr 2024168-2024-02915-00 and 2024168-2024-02915-01.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18825248
MDR Text Key336788153
Report Number2024168-2024-02675
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P110028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 03/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/04/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1012015-120
Device Lot Number3072561
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/14/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/25/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-